跳至主要内容
临床试验/CTRI/2025/04/084363
CTRI/2025/04/084363尚未招募不适用

Comparison of recovery of neuromuscular blockade of atracurium with neostigmine versus rocuronium with sugammadex in hepatopancreatic biliary surgeries - A Randomised Control Trial

Institute of Liver and Biliary sciences vasant kunj1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年4月17日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Time taken to achieve Train of four ratio of 0.7

研究概览

简要总结

Patients Undergoing major hepatopancreatic biliary surgeries will be given either atracurium for neuromuscular blockade followed by reversal with neostigmine Or rocuronium followed by reversal with sugammadex and time taken to recovery of blockade and heamodynamics will be noted at the end of surgery

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients who give informed consent Patients undergoing major hepatopancreatic biliary surgeries.

排除标准

  • Patients with refusal to participate Patients with neuromuscular weakness Acidosis Electrolyte abnormalities Myesthenia gravis.

结局指标

主要结局

Time taken to achieve Train of four ratio of 0.7

时间窗: At 30 second intervals after giving reversal agent

次要结局

  • Time taken to achieve Train of four ratio 0.9(Heamodynamics during extubation)

研究者

发起方
Institute of Liver and Biliary sciences vasant kunj
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Lakshay Manchanda

INSTITUTE OF LIVER AND BILIARY SCIENCES

研究点 (1)

Loading locations...

相似试验